Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Onyekachi Ifudu"'
Autor:
Eli A. Friedman, Onyekachi Ifudu
Publikováno v:
Dialysis & Transplantation. 38:124-127
Alternative medicine treatment, defined broadly as the use of unproven therapies is increasingly popular in the United States. An estimated 40% of the population resorted to alternative medicine regimens in 1999 for either preventive, palliative, or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4262e63b448de180fbae652d84f1348
https://doi.org/10.1002/dat.20316
https://doi.org/10.1002/dat.20316
Autor:
Onyekachi Ifudu
Is the nephrology community facilitating excess cardiovascular deaths in patients with kidney failure and anemia by treating to a subnormal hematocrit? Why have clinicians and nephrologists permitted health insurance companies and the government to d
Publikováno v:
Nephrology Dialysis Transplantation. 17:1639-1642
Background. It is speculated, but unconfirmed, that the usual electrocardiographic manifestations of hyperkalaemia are less frequent and less pronounced in persons with end-stage renal disease (ESRD) than in those with normal renal function. We studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90b28d1338086a52d05005e04cc0be55
https://doi.org/10.1093/ndt/17.9.1639
https://doi.org/10.1093/ndt/17.9.1639
Autor:
Onyekachi Ifudu
Publikováno v:
Nephrology Dialysis Transplantation. 17:38-41
Suboptimal response to recombinant human erythropoietin (rHuEPO) is common in a substantial percentage of patients with chronic kidney disease. Consequently, a higher dose of rHuEPO is needed to attain target haematocrit (Hct) in such patients. Varia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::368b88bdea374a6b62fe6467a65b0bf5
https://doi.org/10.1093/ndt/17.suppl_5.38
https://doi.org/10.1093/ndt/17.suppl_5.38
Autor:
Imran Rajwani, Georgina Delosreyes, Vera Vlacich, Eli A. Friedman, Kathy Reydel, Jaime Uribarri, Onyekachi Ifudu
Publikováno v:
American Journal of Nephrology. 22:363-368
Background: Though interdialytic weight gain (IDWG) is used as an index of fluid and dietary compliance among hemodialysis patients, neither its clinical correlates nor an actual ‘normal range’ is established. Consequently, clinicians impose unif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a3c7389ce7e30c65c9211190304e16a
https://doi.org/10.1159/000065228
https://doi.org/10.1159/000065228
Autor:
Onyekachi Ifudu, Antoinette Fowler
Publikováno v:
ASAIO Journal. 47:569-572
In patients with end-stage renal disease (ESRD), viral or bacterial infections are postulated to abolish or impair response to recombinant erythropoietin (Epogen). However, previous reports revealed that response to Epogen among hemodialysis patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad37ea287cbe43070a8acf8f8de9c541
https://doi.org/10.1097/00002480-200109000-00035
https://doi.org/10.1097/00002480-200109000-00035
Autor:
Kathy Reydel, Georgina Delosreyes, Onyekachi Ifudu, Eli A. Friedman, Imran Rajwani, Vera Vlacich, Jaime Uribarri
Publikováno v:
American Journal of Kidney Diseases. 38:518-522
Several investigators reported that individuals with diabetes and women on hemodialysis treated with recombinant erythropoietin (EPO) attained lower hematocrits than individuals without diabetes and men. It is unclear whether these observed differenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff4ce906b5ca8ffaf12ca44452f05f7a
https://doi.org/10.1053/ajkd.2001.26842
https://doi.org/10.1053/ajkd.2001.26842
Autor:
Onyekachi Ifudu
Publikováno v:
Cleveland Clinic Journal of Medicine. 68:643-648
Anemia, a common complication of HIV infection, is associated with morbidity and shortened survival. HIV-associated anemia can often be corrected with erythropoietin (EPO) therapy, which is safer than blood transfusion. Because the response to erythr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54332a87b73be861d597566efbbd07e4
https://doi.org/10.3949/ccjm.68.7.643
https://doi.org/10.3949/ccjm.68.7.643
Autor:
Vera Vlacich, Onyekachi Ifudu, Georgina Delosreyes, Jaime Uribarri, Eli A. Friedman, Kathy Reydel, Imran Rajwani
Publikováno v:
American Journal of Kidney Diseases. 36:1166-1174
Despite the clearly established relationship between adequacy of dialysis and response to erythropoietin, recent guidelines on anemia management in end-stage renal disease (ESRD) omit mention of dialysis adequacy while advocating the use of large amo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24857a024e8c32d3dba8b9f7cbffbfcc
https://doi.org/10.1053/ajkd.2000.19830
https://doi.org/10.1053/ajkd.2000.19830